As PDUFA Data Nears, Roflumilast Foam 0.3% (Zoryve, Arcutis) Improves Scalp and Body Pso Symptoms, Including Itch, in Phase 3 Study
Roflumilast foam 0.3% (Zoryve, Arcutis) performed well as a once-daily monotherapy treatment for psoriasis of the scalp and body, according to new Phase 3 data in the Journal of American Medical Association (JAMA).